OBESITY

Obesity is one of the most common metabolic disorders and is characterised by an increase in the proportion of fatty tissue in relation to the total body weight. In most cases it is due to an imbalance between energy intake and output. This disorder constitutes an important public health problem due to its prevalence in developed countries and its association to a high rate of mortality, multiple complications or chronic illnesses.

The focus for the treatment of obesity should start with nutritional and dietary care, physical activity and changes in lifestyle. Nevertheless, in the case of a situation that cannot be controlled by the above measures the use of pharmaceutical products should be considered.

This pharmacy's team has selected the following pharmaceutical novelties and other natural products:

Acomplia

acomplia

 ACOMPLIA® (rimonabant) approved in the European Union as an adjunct to diet and exercise for the treatment of obese patients (BMI> 30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factors such as type 2 diabetes or dyslipidemia.

Xenical (Orlistat) 120mg 84 tablets:

xenical

Xenical acts on the digestive tract diminishing the absorption of up to 30% of fats ingested, eliminating them directly from the intestine.

Reductil (Sibutramine) 10-15mg 28, 56 & 98 tablets:

reductil

 

Reductil is a new drug that acts on two fundamental levels increasing satiation and output of energy.
Full Minceur System
full minceur system

Full Minceur System

Nutritional supplement from laboratories Pierre Fabre.
4.3.2.1 Minceur Chrono

4.3.2.1 Minceur chrono

Nutritional supplement from laboratories Arkopharma

3 Jours Express
3 jours express

Nutritional supplement from laboratories 3 Chênes in 3 days.
Hydroxyblast
hydroxyblast

Nutritional supplement from laboratories Scientic Nutrition.

Enerzona
 THE BENEFITS OF THE ZONE:
  • Improve efficiency
  • Slim without hunger
  • Attain wellbeing
Zantrex 3
zantrex 3
Zantrex 3 is a new kind of high-energy diet pill.

Lipo-stop:

lipo-stop

 

Neutralises fats in foods.
Oligofaim 80 tablets:
 Reduces appetite in a natural way.
Oligodrain 200 ml:
 Eliminates fats and tones the body quickly losing the first few kilos.
Oligobrul 90 tablets:
 Burns up the calories, activating the elimination of fats.
Minciplus 20 amp:
 A natural product that facilitates drainage stimulates circulation and burns up body fats.
Phytaminceur 24 amp:
a natural product that burns up body fats, eliminates water and toxins from the system and encourages digestion.
Lipodrainage 120 tablets/200ml:
A drainage treatment.
Citriglucane 500 50 tablets:
A natural product that blocks the absorption and aids the elimination of fats.
Adipos forte
ADIPOS FORTE

 

LEGAL INFORMATION
  • General conditions: the information provided from Roser Miro Pharmacy's Web is directed to complement, not to substitute the existent relationship between a patient and his or her doctor.
  • Privacy and confidentiality policy: Whatever communication conveyed through the Web of Roser Miró Pharmacy is strictly confidential; although the electronic addresses and their content can be kept, your information will not be shared with any external source.
  • Legislation: This Web is managed by Roser Miró pharmacy, legally established in Escaldes, Principality of Andorra. The terms and conditions of usage of this Web are protected under the laws that rule in Andorra. Equally all its products and medicines have been authorized by the Health and Social Health Ministry of the Government of Andorra.
  • Links: The Web of the pharmacy contains links to other Webs, normally those of the labs which manufacture the different products. These links are offered as services and information to provide the maximum information about the products, medicines and treatments, relative to health and well-being.
  • Financing and advertising: This Web neither receives nor has any financing from advertising.
  • The information of this web has been produced by the pharmacists of Roser Miró Pharmacy's team, starting from approvals and subsequent information from the European medicines agency www.emea.europa.eu and the USA Food and Drug administration www.fda.gov and from the manufacturing pharmaceutical laboratories.

Webmaster: fidex@andorra.ad

Last modified: 7 September 2007